For healthcare professionals in the UK and ROI only
GPnotebook

This promotional website has been developed and funded by Boehringer Ingelheim.
The media partners for this activity are GPnotebook and Diabetes on the net. GPnotebook and Diabetes on the net have had no input into the content of this website.

Prescribing information for the United Kingdom and the Republic of Ireland.
Adverse event reporting information can be found at the bottom of the page.

About.

Welcome to the T2D Talks Hub, an educational platform designed to equip HCPs with resources supporting the management of people living with T2D.

What this hub provides:

This hub offers insightful resources in a range of formats:

  • Discover educational video-based content and practical, downloadable leaflets on key areas in T2D, to support your clinical practice.
  • Explore downloadable leaflets designed for patients to further their knowledge and support engagement with their diabetes-related health.

Managing type 2 diabetes in adults:
applying the NICE NG28 update beyond the non-complex patient

Nadia Malik and Dr Waqas Tahir

Watch our latest on-demand videos about the 2026 updates to the NICE NG28 guideline and how this affects clinical practice.

Access now

The evolving landscape:
Type 2 diabetes management and diabetes-related mental health – a summary

Professor Richard Holt & Nicola Milne

Check out an educational summary video exploring the impact of mental wellbeing in T2D, including recognising psychological challenges, the importance of education and integrated care, and practical management strategies through case-based learning.

Access now

Download factsheets designed to support you with the best practice for managing T2D and complex comorbidities, addressing treatment non-adherence, and recommendations for managing T2D during Ramadan and periods of fasting.

Access now

Access patient leaflets, designed to support and educate adults living with T2D.

Access now

Focus on: T2D and Frailty

Did you know?

13-48%

Roughly 13-48% of people living with diabetes are also living with frailty.1-4

Over-treatment of older, frail adults living with T2D is common as a result of regimen intensification over prior pre-frail years or after acute hospital admissions.5 Simplification, switching or de-escalation of the therapeutic regimen, depending on their level of frailty and HbA1c levels, may be required in elderly people living with T2D and frailty.5
Therefore, guidelines recommend that an individualised and holistic approach should be taken with less stringent glycaemic targets.6 This is because quality of life should be supported owing to a shorter life expectancy and increased vulnerability to the serious adverse effects of hypoglycaemia.7,8

A four-step guide to individualised management of people with frailty and T2D

Step one: Set individualised glycaemic targets

  • Consider therapies with low incident rates of hypoglycaemia.5

Step two: Consider de-escalation of therapy

  • HCPs should consider de-escalating intensive therapy regimens if the patient may not live to benefit from their long-term effects on health and QoL.5

Step three: Appropriate diet and exercise

  • Mild-intensity exercise and optimal nutrition are recommended to improve the health and QoL of people living with T2D and frailty.5,9

Step four: Assess frailty regularly

  • Assess frailty annually as a minimum, or earlier if there has been a change in health status and three months after any intervention (e.g., hospitalisation, weight loss).5
For further information to assess levels of frailty, please refer to the Rockwood Clinical Frailty Scale (external resource that Boehringer Ingelheim has no influence over)10

Resources.

Patient leaflet

What has diabetes got to do with my kidneys?

CKD risk increases with age, and more than three in 10 people with advanced CKD experience frailty. Declining kidney function can contribute to frailty through poor nutrition, muscle loss, cognitive changes and other comorbidities.11

Download a one-page leaflet for your patients which outlines the purpose of kidney screenings and the importance of returning urine samples. This leaflet was made in collaboration with Sanjay Mistry, an expert through experience who himself was living with diabetes, using patient-friendly language.

Download leaflet here

HCP leaflet

Managing type 2 diabetes in adults: applying the NICE NG28 update beyond the non-complex patient

Discover an educational leaflet designed to support HCPs in understanding the updated NICE NG28 guidelines for managing type 2 diabetes in adults, with case-based examples to help apply this knowledge to practical, everyday clinical scenarios.

Download leaflet here

Back to top

CKD: chronic kidney disease; HbA1c: glycated haemoglobin A1c; HCP: healthcare professional; NICE: National Institute of Health and Care Excellence; QoL: quality of life; T2D: type 2 diabetes.

Please review the Summary of Product Characteristics for Linagliptin for the full information on dosing, adverse events, contraindications, special warnings and precautions for use before prescribing. Available at: www.medicines.org.uk (UK) and https://www.medicines.ie (ROI).12

References

  1. Hanlon P, et al. Lancet Public Health. 2018;3(7):e323–32.
  2. Hanlon P, et al. Lancet Healthy Longev. 2020;1(3):e106–16.
  3. Yoon S-J, Kim K-I. Ann Geriatr Med Res. 2019;23(4):165–9.
  4. Morley JE, et al. J Am Med Dir Assoc. 2014;15(12):853–9.
  5. Strain DW, et al. Diabetes Ther. 2021;12(5):1227–1247.
  6. NICE (2026). Type 2 diabetes in adults: management. Available at: https://www.nice.org.uk/guidance/ng28 (accessed October 2026).
  7. Strain DW, et al. Diabet Med. 2018;35(7):838–845.
  8. Hanlon P, et al. Commun Med (Lond). 2021;1:28.
  9. Bahat G, et al. Drugs Aging. 2023;40(9):751–761.
  10. NHS England. Clinical Frailty Scale. Available at: https://www.england.nhs.uk/south/wp-content/uploads/sites/6/2022/02/rockwood-frailty-scale_.pdf (accessed October 2026).
  11. National Kidney Federation. Ageing Well with Kidney Disease: Preventing Frailty. Available at: https://www.kidney.org.uk/ageing-well-with-kidney-disease-preventing-frailty (accessed October 2026).
  12. Linagliptin Summary of Product Characteristics. Available at: https://www.medicines.org.uk (UK) and https://www.medicines.ie (ROI).

Prescribing information for the United Kingdom and the Republic of Ireland.

Linagliptin is indicated in adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control as12:
• monotherapy when metformin is inappropriate due to intolerance, or contraindicated due to renal impairment
• in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

This promotional website has been developed and funded by Boehringer Ingelheim.
Editorial support for this website has been provided by OmniaMed Communications.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (UK) or https://www.hpra.ie/homepage/about-us/report-an-issue (IRE). Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 0800 328 1627 (freephone) (UK) or 01 2913960 (IRE), or by email: [email protected]

PC-GB-112303 V3 | October 2026

Linagliptin prescribing information: UK and ROI.

Empagliflozin prescribing information: UK and ROI.

This website is for healthcare professionals in the United Kingdom and Republic of Ireland only.

To continue, please confirm that you are a healthcare professional in the United Kingdom or the Republic of Ireland by clicking below.

I am
I am not

Linagliptin prescribing information: UK and ROI.

You are leaving https://resources.gpnotebook.com

Text

Text

Close

You are leaving this site.

You are now leaving https://resources.gpnotebook.com/moving-forward-in-type-2-diabetes-management-with-glp-1ras-resource-hub/.
Links to external website are provided as a resource to the viewer.
This website is neither owned or controlled by Novo Nordisk.
Novo Nordisk accepts no responsibility for the content or services of the linked site.

OK
Cancel